{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T06:49:31Z","timestamp":1775112571415,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2014 Id 15374"],"award-info":[{"award-number":["IG 2014 Id 15374"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3784-5","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T06:56:13Z","timestamp":1511333773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol"],"prefix":"10.1186","volume":"17","author":[{"name":"the Andromeda working group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9525-6070","authenticated-orcid":false,"given":"Livia","family":"Giordano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Petracci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Chiorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nereo","family":"Segnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,22]]},"reference":[{"key":"3784_CR1","volume-title":"Food, nutrition, physical activity, and the prevention of cancer: a global perspective","author":"World Cancer Research Fund\/American Institute for Cancer Research","year":"2007","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR; 2007."},{"key":"3784_CR2","unstructured":"I numeri del cancro in Italia. 2016. \nhttp:\/\/www.registri-tumori.it\/cms\/it\/node\/4572\n\n. Assessed 22 May 2017."},{"key":"3784_CR3","volume-title":"IARC handbooks of cancer prevention: breast cancer screening","author":"International Agency for Research on Cancer","year":"2016","unstructured":"International Agency for Research on Cancer. IARC handbooks of cancer prevention: breast cancer screening, vol. 15. Lyon: IARC Press; 2016."},{"issue":"3 Suppl 1","key":"3784_CR4","first-page":"21","volume":"39","author":"L Ventura","year":"2015","unstructured":"Ventura L, Giorgi D, Giordano L, Frigerio A, Mantellini P, Zappa M. Italian breast screening survey group. Mammographic breast cancer screening in Italy: 2011-2012 survey. Epidemiol Prev. 2015;39(3 Suppl 1):21\u20139.","journal-title":"Epidemiol Prev"},{"key":"3784_CR5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(99)06065-1","volume":"355","author":"P G\u00f8tzsche","year":"2000","unstructured":"G\u00f8tzsche P, Olsen O. Is screening with mammography for breast cancer justifiable? Lancet. 2000;355:129\u201334.","journal-title":"Lancet"},{"key":"3784_CR6","doi-asserted-by":"crossref","unstructured":"Baum M. Harms of breast cancer screening outweigh benefits if deaths caused by treatment are included. BMJ. 2013:346\u2013f385.","DOI":"10.1136\/bmj.f385"},{"issue":"Suppl 1","key":"3784_CR7","first-page":"5","volume":"19","author":"EUROSCREEN Working Group","year":"2012","unstructured":"EUROSCREEN Working Group. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of benefit and harm balance sheet. J Med Screen. 2012;19(Suppl 1):5\u201313.","journal-title":"J Med Screen"},{"key":"3784_CR8","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-151-10-200911170-00010","volume":"151","author":"JS Mandelblatt","year":"2009","unstructured":"Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151:738\u201347.","journal-title":"Ann Intern Med"},{"issue":"5","key":"3784_CR9","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/bcr3493","volume":"15","author":"SA Eccles","year":"2013","unstructured":"Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, et al. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res. 2013;15(5):R92.","journal-title":"Breast Cancer Res"},{"key":"3784_CR10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.7326\/0003-4819-156-9-201205010-00002","volume":"156","author":"NT van Ravesteyn","year":"2012","unstructured":"van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, et al. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med. 2012;156:609\u201317.","journal-title":"Ann Intern Med"},{"key":"3784_CR11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-155-1-201107050-00003","volume":"155","author":"JT Schousboe","year":"2011","unstructured":"Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and costeffectiveness. Ann Intern Med. 2011;155:10\u201320.","journal-title":"Ann Intern Med"},{"key":"3784_CR12","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/bjc.2011.118","volume":"104","author":"N Pashayan","year":"2011","unstructured":"Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, Neal DE, et al. Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer. 2011;104:1656\u201363.","journal-title":"Br J Cancer"},{"issue":"2","key":"3784_CR13","doi-asserted-by":"crossref","first-page":"e86858","DOI":"10.1371\/journal.pone.0086858","volume":"9","author":"E Vilaprinyo","year":"2014","unstructured":"Vilaprinyo E, Forn\u00e9 C, Carles M, Sala M, Pla R, Castells X, et al. Cost-effectiveness and harm-effectiveness analyses of risk-based screening strategies for breast cancer. PLoS One. 2014;9(2):e86858.","journal-title":"PLoS One"},{"issue":"10","key":"3784_CR14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamaoncol.2016.1025","volume":"2","author":"P Maas","year":"2016","unstructured":"Maas P, Barrdahl M, Joshi AD, Auer PL, Gaudet MM, Milne RL, et al. Breast cancer risk from modifiable and nonmodifiable risk factors among white women in the United States. JAMA Oncol. 2016;2(10):1295\u2013302.","journal-title":"JAMA Oncol"},{"issue":"1","key":"3784_CR15","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/bcr3110","volume":"14","author":"H Darabi","year":"2012","unstructured":"Darabi H, Czene K, Zhao W, Liu J, Hall P, Humphreys K. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement. Breast Cancer Res. 2012;14(1):R25.","journal-title":"Breast Cancer Res"},{"issue":"6","key":"3784_CR16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ng.586","volume":"42","author":"C Turnbull","year":"2010","unstructured":"Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet. 2010;42(6):504\u20137.","journal-title":"Nat Genet"},{"key":"3784_CR17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng.2563","volume":"45","author":"K Michailidou","year":"2013","unstructured":"Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013;45:353\u201361.","journal-title":"Nat Genet"},{"key":"3784_CR18","doi-asserted-by":"crossref","unstructured":"Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, et al. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. 2015;107(5).","DOI":"10.1093\/jnci\/djv036"},{"issue":"1\u20132","key":"3784_CR19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10555-012-9414-4","volume":"32","author":"DS Guttery","year":"2013","unstructured":"Guttery DS, Blighe K, Page K, Marchese SD, Hills A, Coombes RC, et al. Hide and seek: tell-tale signs of breast cancer lurking in the blood. Cancer Metastasis Rev. 2013;32(1\u20132):289\u2013302.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"3784_CR20","doi-asserted-by":"crossref","first-page":"e53141","DOI":"10.1371\/journal.pone.0053141","volume":"8","author":"EK Ng","year":"2013","unstructured":"Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma ES, et al. Circulating microRNAs as specific biomarkers for breast cancer detection. PLoS One. 2013;8(1):e53141.","journal-title":"PLoS One"},{"issue":"3","key":"3784_CR21","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/bcr3428","volume":"15","author":"AC Godfrey","year":"2013","unstructured":"Godfrey AC, Xu Z, Weinberg CR, Getts RC, Wade PA, Deroo LA, et al. Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the sister study cohort. Breast Cancer Res. 2013;15(3):R42.","journal-title":"Breast Cancer Res"},{"issue":"13\u201314","key":"3784_CR22","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.cca.2012.02.016","volume":"413","author":"Q Wu","year":"2012","unstructured":"Wu Q, Wang C, Lu Z, Guo L, Ge Q. Analysis of serum genome-wide microRNAs for breast cancer detection. Clin Chim Acta. 2012;413(13\u201314):1058\u201365.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"3784_CR23","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/carcin\/bgs030","volume":"33","author":"Z Hu","year":"2012","unstructured":"Hu Z, Dong J, Wang LE, Ma H, Liu J, Zhao Y, et al. Serum microRNA profiling and breast cancer risk: the use of miR-484\/191 as endogenous controls. Carcinogenesis. 2012;33(4):828\u201334.","journal-title":"Carcinogenesis"},{"issue":"1","key":"3784_CR24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.breast.2013.11.006","volume":"23","author":"F Caumo","year":"2014","unstructured":"Caumo F, Bernardi D, Ciatto S, Macaskill P, Pellegrini M, Brunelli S, et al. Incremental effect from integrating 3Dmammography (tomosynthesis) with 2D-mammography: increased breast cancer detection evident for screening centres in a population-based trial. Breast. 2014;23(1):76\u201380.","journal-title":"Breast"},{"key":"3784_CR25","unstructured":"The European Prospective Investigation into Cancer and Nutrition. \nhttp:\/\/epic.iarc.fr\/\n\n. Assessed 9 Nov 2017."},{"key":"3784_CR26","unstructured":"Brief COPE. \nhttp:\/\/www.psy.miami.edu\/faculty\/ccarver\/sclBrCOPE.html\n\n. Assessed 9 Nov 2017."},{"issue":"1","key":"3784_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1148\/radiol.2015141959","volume":"277","author":"L Morra","year":"2015","unstructured":"Morra L, Sacchetto D, Durando M, Agliozzo S, Carbonaro LA, Delsanto S, et al. Breast cancer: computer-aided detection with digital breast Tomosynthesis. Radiology. 2015;277(1):56\u201363.","journal-title":"Radiology"},{"issue":"3","key":"3784_CR28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0033-8389(01)00017-3","volume":"40","author":"L Liberman","year":"2002","unstructured":"Liberman L, Menell JH. Breast imaging reporting and data system (BI-RADS). Radiol Clin N Am. 2002 May;40(3):409\u201330.","journal-title":"Radiol Clin N Am"},{"key":"3784_CR29","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jnci\/djn326","volume":"100","author":"MS Pepe","year":"2008","unstructured":"Pepe MS, Feng Z, Janes H, Bossuyt PM, Potter JD. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst. 2008;100:1432\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"3784_CR30","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/ijc.28757","volume":"135","author":"J Hu","year":"2014","unstructured":"Hu J, Wang Z, Liao BY, Yu L, Gao X, Lu S, et al. Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients. Int J Cancer. 2014;135(5):1187\u201394.","journal-title":"Int J Cancer"},{"key":"3784_CR31","doi-asserted-by":"crossref","first-page":"25997","DOI":"10.1038\/srep25997","volume":"6","author":"R Hamam","year":"2016","unstructured":"Hamam R, Ali AM, Alsaleh KA, Kassem M, Alfayez M, Aldahmash A, et al. microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection. Sci Rep. 2016;6:25997.","journal-title":"Sci Rep"},{"key":"3784_CR32","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/jnci\/djr172","volume":"103","author":"E Petracci","year":"2011","unstructured":"Petracci E, Decarli A, Schairer C, Pfeiffer RM, Pee D, Masala G, et al. Risk factor modification and projections of absolute breast cancer risk. J Natl Cancer Inst. 2011;103:1037\u201348.","journal-title":"J Natl Cancer Inst"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3784-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T06:56:35Z","timestamp":1511333795000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3784-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,22]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3784"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3784-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,22]]},"article-number":"785"}}